Related Experiment Video
Updated: May 12, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Pediatric status asthmaticus
Christopher L Carroll1, Kathleen A Sala
1Division of Pediatric Critical Care, Department of Pediatrics, Connecticut Children's Medical Center, 282 Washington Street, Hartford, CT 06106, USA. ccarrol@ccmckids.org
Insights
Status asthmaticus, a severe asthma condition, requires prompt pediatric intensive care. This review critically assesses second-line treatments to establish evidence-based guidelines for this critical pediatric condition.
Area of Science:
- Pediatric Intensive Care Medicine
- Pulmonology
- Emergency Medicine
Background:
- Status asthmaticus is a common reason for pediatric intensive care unit (PICU) admission.
- Prompt assessment and aggressive management are crucial for favorable outcomes.
- Current first-line treatments include oxygen, inhaled albuterol, and corticosteroids.
Purpose of the Study:
- To discuss the pathophysiology of status asthmaticus.
- To critically evaluate the existing literature on second-line treatment options.
- To provide an evidence basis for managing severe pediatric asthma exacerbations.
Main Methods:
- Literature review of pathophysiology and treatment of status asthmaticus.
- Critical assessment of studies on second-line therapies.
- Synthesis of evidence to guide clinical practice.
Main Results:
- Status asthmaticus pathophysiology involves complex airway inflammation and bronchoconstriction.
- Limited comparative studies exist for second-line treatments, leading to variable clinical practice.
- Evidence for therapies like magnesium sulfate, ketamine, and heliox is reviewed.
Conclusions:
- There is a need for more high-quality, comparative studies on second-line treatments for status asthmaticus.
- Evidence-based guidelines are needed to standardize the variable use of these therapies.
- Optimizing the treatment of status asthmaticus can improve PICU outcomes.
Abstract:
Status asthmaticus is a frequent cause of admission to a pediatric intensive care unit. Prompt assessment and aggressive treatment are critical. First-line or conventional treatment includes supplemental oxygen, aerosolized albuterol, and corticosteroids. There are several second-line treatments available; however, few comparative studies have been performed and in the absence of good evidence-based treatments, the use of these therapies is highly variable and dependent on local practice and provider preference. In this article the pathophysiology and treatment of status asthmaticus is discussed, and the literature regarding second-line treatments is critically assessed to apply an evidence basis to the treatment of this severe disease.
Related Concept Videos
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Acute Respiratory Failure-III